Definitive Contract HT942524C0075
Award Date
9/20/24
Potential Completion Date
1/19/27
Potential Value
$1.3M
Federal Agency
Defense Health Agency
Awardee
Emergingdx Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Mansfield, MA 02048, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
STTR Phase II
Primary Consortia Member
Not listed
Similar Awards
The Defense Health Agency (DHA) awarded a $249,837.63 Small Business Technology Transfer (STTR) Phase I contract to Emergingdx Inc., a small business subchapter S corporation based in Mansfield, Massachusetts. The contract is for the development of an automated detection platform for circulating and exosomal microRNAs, with potential applications in early disease detection and precision medicine. This contract is part of the DHA's research and development efforts in advanced diagnostic and...
This federal contract award is for a Small Business Innovation Research (SBIR) Phase I project from the Defense Health Agency (DHA) to Emergingdx Inc., a small business subchapter S corporation based in Mansfield, Massachusetts. The contract, valued at $249,993.61, supports the development of a "Rapid, Automated, Multiplexed Omics Platform" for medical research and diagnostic applications. As a total small business set-aside contract, this award demonstrates Emergingdx Inc.'s expertise...
This is a Small Business Technology Transfer (STTR) Phase I contract awarded by the Office of Naval Research (ONR) to Emergingdx Inc., a small business subchapter S corporation based in Mansfield, Massachusetts. The $246,350.00 firm fixed-price contract supports the development of an advanced diagnostic and biosensor technology platform for medical research and precision medicine applications, with a focus on disease detection, biomarker analysis, and rapid diagnostic solutions. The contract...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Department of the Army Materiel Command to Dxdiscovery Inc., a for-profit Subchapter S corporation, to conduct research and development efforts. The total award amount is $999,995.10, and the contract has a firm fixed price pricing type. The contract was awarded on December 20, 2017, with a completion date of February 13, 2020. The contract is set aside for total small business participation, and the potential...
Earlydiagnostics Inc., doing business as Earlydx, was awarded a $395,918 firm fixed price contract by the National Institutes of Health National Cancer Institute under the Small Business Innovation Research program. The contract has a total small business set aside designation. Earlydx will provide cloud-based development of a liquid-biopsy platform for the Cancer Research Data Commons, as requested in Topic 428 of the NIH/CDC SBIR solicitation seeking proposals for next generation...
This is a $1,994,911 firm fixed price contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Earlydiagnostics Inc., doing business as Earlydx. The contract is part of the NCI's Small Business Innovation Research (SBIR) program and has a total small business set-aside designation. The contract supports Earlydx's research and development of a cloud-based liquid-biopsy platform for the Cancer Research Data Commons. Earlydx is a for-profit...
<p>This federal contract award W81XWH15C0163 was issued by the U.S. Army Medical Command (MEDCOM) to Dxdiscovery Inc., a small business concern, under the Small Business Innovation Research (SBIR) program. The $149,714.90 firm-fixed-price contract is for Phase I of an SBIR project with a completion date of April 28, 2016. The contract is a definitive contract and has a total small business set-aside designation.</p>
<p>This is a $199,969 Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Accelerated Medical Diagnostics, Inc. The contract is for "OTHER FUNCTIONS - R & D BIOMEDICAL (BASIC RESEARCH)" and has a firm fixed price pricing type with a completion date of September 30, 2016. As an SBIR Phase I award, this contract supports early-stage research and development activities.</p>
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Health Agency (DHA) to Firebird Biomolecular Sciences LLC, a for-profit limited liability company, for the development of "Innovative DNA for Highly Multiplexed Molecular Diagnostics". The $249,956.88 firm-fixed-price contract has a period of performance ending on May 8, 2025. The contract supports research and development of novel molecular technologies to create a rapid, point-of-sampling...
This is a federal contract award (W911QY15C0058) made by the Joint PEO Chemical and Biological Defense, a Defense agency, to Dxdiscovery Inc., a small business, under the SBIR (Small Business Innovation Research) Program Phase II. The contract is a definitive, firm-fixed-price contract with a ceiling value of $999,822.46 and a period of performance ending on May 25, 2017. The contract is set aside for total small business participation. No additional details on the specific products or...